☆ 4.7 Editorial Material

Targeting the Jak/Signal Transducer and Activator of Transcription 3 Pathway with Ruxolitinib in a Mouse Model of Recessive Dystrophic Epidermolysis BullosaeSquamous Cell Carcinoma

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)

Get Full Text
Add to Collection

Journal

JOURNAL OF INVESTIGATIVE DERMATOLOGY
Volume 141, Issue 4, Pages 942-946

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jid.2020.08.022

Keywords

-

Categories

Dermatology

Funding

  1. Epidermolysis Bullosa Research Partnership grant

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.